Driehaus Capital Management’s VectivBio Holding AG Ordinary Shares VECT Stock Holding History

Driehaus Capital Management’s Portfolio VECT Stock Details VECT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-1,768,198	Closed	-$15.2M	–	487
2023 Q1	$15.2M	Buy	1,768,198 +51,542	+3%	+$425K	0.21%	154
2022 Q4	$14.8M	Buy	1,716,656 +861,921	+101%	+$6.94M	0.22%	154
2022 Q3	$5.13M	Sell	854,735 -10,494	-1%	-$57K	0.08%	270
2022 Q2	$4.67M	Buy	865,229 +471,864	+120%	+$2.54M	0.08%	279
2022 Q1	$1.85M	Sell	393,365 -9,754	-2%	-$51K	0.02%	320
2021 Q4	$1.98M	Sell	403,119 -16,987	-4%	-$83.7K	0.02%	303
2021 Q3	$3.25M	Sell	420,106 -35,910	-8%	-$308K	0.04%	312
2021 Q2	$5.32M	Buy	+456,016	New	+$6.92M	0.07%	275

Other funds holding VECT

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Driehaus Capital Management's VECT Position: Q2 2023 in Review

Driehaus Capital Management sold out of VectivBio Holding AG Ordinary Shares (VECT) in Q2 2023, closing a stake of 1,768,198 shares — an estimated $15.2M sold.

Driehaus Capital Management first reported a position in VECT in Q2 2021 and held it in 8 quarters. The position peaked at $15.2M in Q1 2023. 49 funds tracked by Wall St. Rank hold VECT as of Q2 2023.

Driehaus Capital Management reported no remaining VectivBio Holding AG Ordinary Shares position as of Q2 2023 after selling out during the quarter.
Driehaus Capital Management sold 1,768,198 VectivBio Holding AG Ordinary Shares shares in Q2 2023, an estimated $15.2M.
Driehaus Capital Management first reported a position in VectivBio Holding AG Ordinary Shares in Q2 2021 and held it in 8 quarters.
Driehaus Capital Management's VectivBio Holding AG Ordinary Shares position peaked at $15.2M in Q1 2023.
49 funds tracked by Wall St. Rank held VectivBio Holding AG Ordinary Shares as of Q2 2023.

Based on Driehaus Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.